The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 4 , Pages 963-970 , April 2009

Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure

  • Daniel Zimpfer, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationAddress for reprints: Daniel Zimpfer, MD, Department of Cardiothoracic Surgery, Medical University of Vienna, Wahringer Guertel 18-20, A-1090 Vienna, Austria.
    • ,
  • Seyedhossein Aharinejad, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • Laboratory for Cardiovascular Research, Department of Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria
    • ,
  • Johannes Holfeld, MS

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • Anita Thomas, MS

      Affiliations

    • Laboratory for Cardiovascular Research, Department of Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria
    • ,
  • Julia Dumfarth, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • Raphael Rosenhek, MD

      Affiliations

    • Department of Internal Medicine, Medical University of Vienna, Vienna, Austria
    • ,
  • Martin Czerny, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • Wolfgang Schaden, MD

      Affiliations

    • AUVA Trauma Center, Vienna, Austria
    • ,
  • Mathias Gmeiner, MD

      Affiliations

    • Laboratory for Cardiovascular Research, Department of Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria
    • ,
  • Ernst Wolner, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • Michael Grimm, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria

Received 19 August 2008 ,Revised 20 October 2008 ,Accepted 2 November 2008.

References 

  1. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007–2018
  2. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation. 2006;114:2823–2830
  3. Gutersohn A. Shock waves upregulate vascular endothelial growth factor m-RNA in human umbilical vascular endothelial cells. Circulation. 2000;102(suppl):18
  4. Meirer R, Brunner A, Deibl M, Oehlbauer M, Piza-Katzer H, Kamelger FS. Shock wave therapy reduces necrotic flap zones and induces VEGF expression in animal epigastric skin flap model. J Reconstr Microsurg. 2007;23:231–236
  5. Meirer R, Huemer GM, Oehlbauer M, Wanner S, Piza-Katzer H, Kamelger FS. Comparison of the effectiveness of gene therapy with vascular endothelial growth factor or shock wave therapy to reduce ischaemic necrosis in an epigastric skin flap model in rats. J Plast Reconstr Aesthetic Surg. 2007;60:266–271
  6. Schaden W, Thiele R, Kolpl C, Pusch M, Nissan A, Attinger CE, et al. Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J Surg Res. 2007;143:1–12
  7. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation. 1988;78:186–201
  8. Pode D, Landau EL, Lijovetzky G, Shapiro A. Isolated pulmonary blast injury in rats—a new model using the extracorporeal shockwave lithotriptor. Mil Med. 1989;154:288–293
  9. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8
  10. Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther V. First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol. 1982;127:417–420
  11. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110:3055–3061
  12. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis. 2006;17:63–70
  13. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis. 2007;18:397–404
  14. Khattab AA, Brodersen B, Schuermann-Kuchenbrandt D, Beurich H, Tolg R, Geist V, et al. Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. Int J Cardiol. 2007;121:84–85
  15. Malhotra V, Rosen RJ, Slepian RL. Life-threatening hypoxemia after lithotripsy in an adult due to shock-wave-induced pulmonary contusion. Anesthesiology. 1991;75:529–531
  16. Post MJ, Laham R, Sellke FW, Simons M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res. 2001;49:522–531
  17. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis?. Nat Med. 2000;6:1102–1103
  18. Hendel RC, Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation. 2000;101:118–121
  19. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996;348:370–374
  20. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998;98:2800–2804
  21. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114–1123
  22. Isner JM. Myocardial gene therapy. Nature. 2002;415:234–239
  23. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–395
  24. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 2001;49:543–553
  25. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831–840
  26. Wang FS, Wang CJ, Huang HJ, Chung H, Chen RF, Yang KD. Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells. Biochem Biophys Res Commun. 2001;287:648–655
  27. Seidl M, Steinbach P, Worle K, Hofstadter F. Induction of stress fibres and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics. 1994;32:397–400
  28. Gotte G, Amelio E, Russo S, Marlinghaus E, Musci G, Suzuki H. Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment. FEBS Lett. 2002;520:153–155
  29. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182–1189
  30. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 1996;226:316–327
  31. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 2001;103:1920–1927
  32. Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol. 2006;47:1777–1785
  33. Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation. 2004;110:1387–1391
  34. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation. 2005;112:3174–3183

 Supported by a research grant provided by CRT/MTS-Europe GmbH, Konstanz, Germany.

PII: S0022-5223(08)01937-5

doi: 10.1016/j.jtcvs.2008.11.006

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 4 , Pages 963-970 , April 2009

Article Tools

* Image Usage & Resolution